Medicus Pharma Ltd. (MDCX) Stock
Medicus Pharma stock price chart
MDCX stock quote & key statistics
Medicus Pharma annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$25.4M | -$2.37 |
| FY2024 | $0 | -$11.2M | -$0.98 |
| FY2023 | $0 | -$5.3M | -$0.23 |
| FY2022 | $0 | -$1.7M | — |
| FY2021 | $0 | -$2.1M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About Medicus Pharma Ltd.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Medicus Pharma stock FAQ
What is the Medicus Pharma stock ticker symbol?
Medicus Pharma Ltd. trades on the NASDAQ under the ticker symbol MDCX.
What sector and industry is Medicus Pharma in?
Medicus Pharma Ltd. is classified in the Healthcare sector, Drug Manufacturers - General industry.
How many employees does Medicus Pharma have?
Medicus Pharma Ltd. has about 16 full-time employees.
What were Medicus Pharma's revenue and earnings last fiscal year?
Medicus Pharma reported revenue of $0 and net income of -$25.4M in fiscal 2025, with earnings per share of -$2.37.
When did Medicus Pharma go public?
Medicus Pharma stock began trading on February 3, 2016.